Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single Center, Single Dose, Open-Label, Two-Period Replicate Pilot Study to Investigate Intra-subject Variability in the Bioavailability of a Formulation Containing Chlorpromazine Hydrochloride (25 mg Sugar Coated Tablets) in at Least 16 Healthy Males and Females Under Fasting Conditions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02943213
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:45.277182+00:00
Published At
2017-10-13T00:00:00+00:00
Record Updated At
2017-11-14
Results Posted At
2017-10-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anti-Psychotic", "Management of Manifestations of Psychotic Disorders", "Treatment of Schizophrenia", "Control Nausea and Vomiting", "Relief of Restlessness and Apprehension Before Surgery", "Acute Intermittent Porphyria", "Adjunct in the Treatment of Tetanus", "Control Manifestations of the Manic Type of Mani-depressive Illness", "Relief of Intractable Hiccups"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-11-14"
protocolSection.identificationModule.nctId
"NCT02943213"
protocolSection.identificationModule.officialTitle
"A Single Center, Single Dose, Open-Label, Two-Period Replicate Pilot Study to Investigate Intra-subject Variability in the Bioavailability of a Formulation Containing Chlorpromazine Hydrochloride (25 mg Sugar Coated Tablets) in at Least 16 Healthy Males and Females Under Fasting Conditions"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-10-13"

Study condition terms

  • Anti-Psychotic (protocolSection.conditionsModule.conditions)
  • Management of Manifestations of Psychotic Disorders (protocolSection.conditionsModule.conditions)
  • Treatment of Schizophrenia (protocolSection.conditionsModule.conditions)
  • Control Nausea and Vomiting (protocolSection.conditionsModule.conditions)
  • Relief of Restlessness and Apprehension Before Surgery (protocolSection.conditionsModule.conditions)
  • Acute Intermittent Porphyria (protocolSection.conditionsModule.conditions)
  • Adjunct in the Treatment of Tetanus (protocolSection.conditionsModule.conditions)
  • Control Manifestations of the Manic Type of Mani-depressive Illness (protocolSection.conditionsModule.conditions)
  • Relief of Intractable Hiccups (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.